Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

63.33
Delayed Data
As of 4:02pm ET
 -0.16 / -0.25%
Today’s Change
46.01
Today|||52-Week Range
63.74
+8.37%
Year-to-Date
2 Important Dates for Big Pharma
Sep 20 / GuruFocus News - Paid Partner Content
Oncology Space in Focus this Week on ESMO Presentations
Sep 15 / Zacks.com - Paid Partner Content
Roche's (RHHBY) Tecentriq Studies Put on Partial Hold by FDA
Sep 18 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) Collaborates With Halozyme for ENHANZE
Sep 15 / Zacks.com - Paid Partner Content
Bristol-Myers Squibb Stock Still a Beast?
Sep 17 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: Achillion Slumps on End of HCV Deal, Teva Gets a New CEO
Sep 15 / Zacks.com - Paid Partner Content
Time to Adjust as Bristol Myers Squibb Continues Its Climb
Sep 15 / TheStreet.com - Paid Partner Content
Nektar (NKTR) Starts PROPEL Combo Study for Cancer Candidate
Sep 13 / Zacks.com - Paid Partner Content
Bristol Myers Squibb Co. (BMY) is moving higher and higher
Sep 15 / TheStreet.com - Paid Partner Content
Bristol-Myers Reports Positive Results from Melanoma Study
Sep 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close63.49
Today’s open63.35
Day’s range63.03 - 63.74
Volume5,250,092
Average volume (3 months)7,006,166
Market cap$104.1B
Dividend yield2.46%
Data as of 4:02pm ET, 09/21/2017

Growth & Valuation

Earnings growth (last year)+184.95%
Earnings growth (this year)+5.22%
Earnings growth (next 5 years)+9.62%
Revenue growth (last year)+17.31%
P/E ratio23.1
Price/Sales5.05
Price/Book6.53

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.15+0.37%
NVONovo Nordisk-0.05-0.10%
CELGCelgene-0.46-0.32%
ABTAbbott Laboratories-0.46-0.89%
Data as of 4:02pm ET, 09/21/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)$0.76
Annual revenue (last year)$19.4B
Annual profit (last year)$4.5B
Net profit margin22.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Giovanni Caforio
CFO, EVP &
Head-Global Business Operations
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts